1. Enrollment Statistics (2024)
Medicare now covers more than one in five Americans, with enrollment continuing to grow as baby boomers age into eligibility.
| Coverage Category | Enrollees |
|---|---|
| Total Medicare enrollees | ~67 million |
| Part A and B (Original Medicare) | ~32 million |
| Medicare Advantage (Part C) | ~35 million (~52% of all enrollees) |
| Stand-alone Part D plans | ~21 million (plus those in MA-PD) |
| Medigap (supplement) enrollees | ~14 million |
| Dual eligibles (Medicare + Medicaid) | ~12 million |
| Part A only (rare; working uninsured) | ~1% of total |
Medicare Advantage enrollment has surged from 13% of all enrollees in 2003 to over 52% in 2024 — a transformation in how Americans receive Medicare benefits. Medicare Advantage guide →
2. Spending Statistics
Medicare expenditures are approaching $1 trillion annually, making the program one of the largest components of the federal budget.
| Spending Category | Amount |
|---|---|
| Total Medicare expenditures (2023) | ~$944 billion |
| Share of federal budget | ~14% |
| Average annual per-beneficiary spending | ~$14,000 |
| Part A (hospital) spending | ~$323 billion |
| Part B (medical) spending | ~$406 billion |
| Part D (prescriptions) spending | ~$134 billion |
| Medicare as % of GDP (current) | ~3.5% |
| Medicare as % of GDP (projected 2050) | ~6% |
Prescription drug spending was ~$120 billion in 2021 (pre-IRA). The Inflation Reduction Act is projected to generate significant savings through drug price negotiation and the new Part D $2,000 out-of-pocket cap. Part D coverage guide →
3. Beneficiary Demographics
| Demographic | Data |
|---|---|
| Age 65+ enrollees | ~56 million (~84% of total) |
| Under-65 enrollees (disability) | ~10 million (~15%) |
| End-Stage Renal Disease (ESRD) | ~500,000 |
| ALS enrollees | ~20,000 |
| Average age of Medicare beneficiary | 73 years |
| Women as share of Medicare population | ~55% |
| White beneficiaries | ~76% |
| Black beneficiaries | ~10% |
| Hispanic beneficiaries | ~8% |
| Asian beneficiaries | ~4% |
| Rural beneficiaries | ~25% |
4. Health Status of Medicare Beneficiaries
Medicare serves a population with significant health complexity. Approximately 67% of Medicare beneficiaries have three or more chronic conditions, and the average beneficiary takes 4.5 prescription medications.
Most Common Chronic Conditions in Medicare
| Condition | Prevalence Among Medicare Enrollees |
|---|---|
| Hypertension (high blood pressure) | 58% |
| High cholesterol | 50% |
| Arthritis | 31% |
| Ischemic heart disease | 29% |
| Diabetes | 27% |
| Chronic kidney disease | 22% |
| Heart failure | 14% |
| Depression | 13% |
The high prevalence of multiple chronic conditions is a primary driver of Medicare spending and underscores the importance of coordinated care.
5. Medicare Advantage Trends
Medicare Advantage has become the dominant way Americans receive Medicare coverage, growing from a niche option to the majority enrollment choice over two decades.
| Metric | Data (2024) |
|---|---|
| MA enrollment (2003) | 5.3 million (13% of Medicare) |
| MA enrollment (2024) | ~35 million (52% of Medicare) |
| Average MA plan choices per county | 43 plans |
| Average weighted MA premium | $18/month |
| MA plans offering $0 premium | ~70% of all plans |
| MA plans with dental coverage | ~96% |
| MA plans with vision coverage | ~97% |
| MA plans with hearing coverage | ~92% |
Despite low premiums, Medicare Advantage plans have network restrictions and variable out-of-pocket costs. Beneficiaries should compare total expected costs, not just the monthly premium. Full Medicare Advantage guide →
6. Part D and Drug Spending
The Inflation Reduction Act has significantly reshaped Medicare drug coverage, most notably with a new $2,000 annual out-of-pocket cap in 2025 and the first-ever drug price negotiation authority.
| Metric | Data |
|---|---|
| Average Part D monthly premium (2025) | ~$40/month |
| Enrollees reaching catastrophic threshold (pre-2025) | ~15% annually |
| $2,000 OOP cap beneficiaries (est., 2025) | ~3 million will see cost reductions |
| Insulin cap under IRA | $35/month — ~3.3 million Medicare insulin users |
| IRA drug negotiation (first round) | 10 drugs negotiated; effective 2026; ~$6 billion projected savings |
Top 10 Medicare Part D Drugs by Spending
These ten drugs account for a disproportionate share of total Part D spending and include anticoagulants, diabetes medications, and cancer treatments:
- Eliquis (apixaban) — anticoagulant
- Xarelto (rivaroxaban) — anticoagulant
- Ozempic (semaglutide) — diabetes/weight management
- Jardiance (empagliflozin) — diabetes/heart failure
- Farxiga (dapagliflozin) — diabetes/heart failure
- Entresto (sacubitril/valsartan) — heart failure
- Humira (adalimumab) — autoimmune conditions
- Stelara (ustekinumab) — autoimmune conditions
- Keytruda (pembrolizumab) — cancer
- Opdivo (nivolumab) — cancer
7. Preventive Services Utilization
Medicare covers a comprehensive set of preventive screenings and wellness visits at no cost to beneficiaries — yet many remain substantially underutilized.
| Preventive Service | Utilization Rate |
|---|---|
| Annual Wellness Visit (AWV) | ~45% of eligible beneficiaries |
| Colonoscopy screening | ~64% of eligible beneficiaries |
| Mammography (Medicare women 40+) | ~63% |
| Flu vaccine | ~55% of Medicare beneficiaries |
| Hepatitis C (HCV) screening | Growing; still underutilized |
8. Financial Assistance Programs
Several programs help low-income Medicare beneficiaries cover premiums, deductibles, and drug costs — but millions of eligible people are not enrolled.
| Program | Current Enrollees |
|---|---|
| Extra Help / Low Income Subsidy (LIS) for Part D | ~14 million |
| Medicare Savings Programs (MSP) | ~9 million |
| Estimated eligible but NOT enrolled in MSP | ~6 million people missing out |
| IRMAA payers (higher-income Part B surcharge) | ~8% of Part B enrollees |
If your income is limited, contact your state Medicaid office or SHIP counselor to apply for Medicare Savings Programs. An estimated 6 million people who qualify are not enrolled. Medicare cost reduction programs →
9. Average Annual Medicare Spending by Condition
Spending varies enormously depending on the beneficiary's primary diagnosis. The most costly conditions are those requiring intensive ongoing treatment or frequent hospitalization.
| Condition | Average Annual Medicare Spending |
|---|---|
| End-stage renal disease (ESRD) | ~$92,000/year |
| Multiple sclerosis | ~$70,000/year |
| Congestive heart failure | ~$27,000/year |
| Diabetes with complications | ~$24,000/year |
| COPD (chronic obstructive pulmonary disease) | ~$22,000/year |
| Cancer (average across types) | ~$21,000/year |
10. Future Projections
The Medicare program faces significant financial and demographic pressures over the coming decades, driven primarily by the continued aging of the baby boomer generation and rising healthcare costs.
- Medicare Trust Fund (HI, Part A): Projected insolvency in 2031 without legislative action, according to the 2024 Medicare Trustees Report.
- Total Medicare enrollment by 2030: Projected to reach approximately 80 million as the remainder of the baby boomer generation ages into eligibility.
- Per-beneficiary cost growth: Projected at approximately 7% annually, driven by new treatments, inflation, and the increasing complexity of the beneficiary population.
- Medicare as % of GDP by 2050: Projected to nearly double from ~3.5% to ~6% of GDP.
Frequently Asked Questions
As of 2024, approximately 67 million Americans are enrolled in Medicare. Of those, about 32 million are in Original Medicare (Parts A and B), and approximately 35 million — just over 52% — are enrolled in Medicare Advantage (Part C) plans. About 21 million have stand-alone Part D prescription drug plans, and roughly 14 million have Medigap supplement coverage. About 12 million are dual eligible for both Medicare and Medicaid.
Total Medicare expenditures in 2023 were approximately $944 billion, approaching $1 trillion. Medicare represents roughly 14% of the federal budget and approximately 3.5% of GDP. The program's per-beneficiary average annual cost is about $14,000. Part B accounts for the largest share (~$406 billion), followed by Part A (~$323 billion) and Part D (~$134 billion). Without legislative reform, costs are projected to continue rising as more baby boomers enroll.
As of 2024, approximately 52% of all Medicare beneficiaries — about 35 million people — are enrolled in Medicare Advantage (Part C) plans. This is a dramatic increase from 2003, when only about 13% of Medicare beneficiaries (5.3 million people) chose Medicare Advantage. Growth has been driven by low or $0 monthly premiums, extra benefits like dental and vision, and an out-of-pocket spending cap not available in Original Medicare. Learn more about Medicare Advantage →
Sources
The statistics on this page are drawn from the following primary sources:
- CMS Medicare & Medicaid Statistical Supplement — Centers for Medicare & Medicaid Services
- Kaiser Family Foundation Medicare Policy Analysis — KFF.org
- Medicare Payment Advisory Commission (MedPAC) Report to Congress — MedPAC.gov
- HHS/CMS Medicare Enrollment Dashboard — CMS.gov
- Medicare Trustees Report 2024 — U.S. Department of the Treasury